Universal life (UL) and some segregated fund contracts can be minefields when mis‑sold. Salespeople love the high commission that incent this sale of, often, an inferior product for the consumer (you)! Recent regulatory reviews in Ontario identified troubling UL sales practices: weak needs analysis, boilerplate recommendations, misleading illustrations, and products placed with clients for whom UL wasn’t a fit.
Why UL Can Be Harmful in the Wrong Hands
- Complex fee structures and rising cost of insurance (COI) that erode cash value and can trigger lapse if underfunded.
- Illustrations that overstate potential by relying on optimistic assumptions; regulators have cautioned about unrealistic marketing.
- Aggressive distribution models and sales incentives that prioritize the product over the client.
Segregated funds, though offering maturity or death guarantees, can carry higher fees and complex reset provisions; suitability hinges on your objectives and the contract terms. Mis‑selling can expose advisors and insurers to liability.
Real‑World Signals of Trouble
- A focus on tax or estate “benefits” with little disclosure of costs, liquidity limits, or funding risk.
- Indexed UL (IUL) hyped with back‑tested performance, later disappointing clients—now spawning litigation in North America. What to Do If You Own One
- Request a full policy ledger (current and projected), fee breakdown, and COI schedule.
- Ask for a suitability memo explaining why the product fit your documented needs at sale.
- Seek counsel if illustrations were misleading or if a lapse/downsizing caused losses; mis‑selling of UL and seg funds is actionable.
